Study EV-103: New cohorts testing enfortumab vedotin alone or in combination with pembrolizumab in muscle invasive urothelial cancer Meeting Abstract


Authors: Hoimes, C. J.; Rosenberg, J. E.; Petrylak, D. P.; Carret, A. S.; Sasse, C.; Chaney, M. F.; Flaig, T. W.
Abstract Title: Study EV-103: New cohorts testing enfortumab vedotin alone or in combination with pembrolizumab in muscle invasive urothelial cancer
Meeting Title: 2020 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 6 Suppl.
Meeting Dates: 2020 Feb 13-15
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-02-20
Language: English
ACCESSION: WOS:000529525900048
PROVIDER: wos
DOI: 10.1200/JCO.2020.38.6_suppl.TPS595
Notes: Meeting Abstract: TPS595 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Eric Rosenberg
    510 Rosenberg